The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi‐site prospective cohort study
Abstract
Background Specialist drug treatment is critical to overdose prevention; methadone maintenance is effective, but we lack evidence for other modalities. We evaluate the impact of a range of treatments for opiate dependence on overdose mortality. Methods Prospective cohort study of 10 454 heroin users entering treatment 1998–2001 in Italy followed‐up for 10 208 person‐years in treatment and 2914 person‐years out of treatment. Standardized overall mortality ratios (SMR) estimate excess mortality risk for heroin users in and out of treatment compared to the general population. Cox models compare the hazard ratio (HR) of overdose between heroin users in treatment and out of treatment. Results There were 41 overdose deaths, 10 during treatment and 31 out of treatment, generating annual mortality rates of 0.1% and 1.1% and SMRs of 3.9 [95% confidence interval (CI) 2.8–5.4] and 21.4 (16.7–27.4), respectively. Retention in any treatment was protective against overdose mortality (HR 0.09 95% CI 0.04–0.19) compared to the risk of mortality out of treatment, independent of treatment type and potential confounders. The risk of a fatal overdose was 2.3% in the month immediately after treatment and 0.77% in the subsequent period; compared to the risk of overdose during treatment the HR was 26.6 (95% CI 11.6–61.1) in the month immediately following treatment and 7.3 (3.3–16.2) in the subsequent period. Conclusions We demonstrate that a range of treatments for heroin dependence reduces overdose mortality risk. However, the considerable excess mortality risk in the month following treatment indicates the need for greater health education of drug users and implementation of relapse and overdose death prevention programmes. Further investigation is needed to measure and weigh the potential benefits and harms of short‐term therapies for opiate use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1×
“Treatment retention should be a key priority for long-term and maintenance therapies as part of an overdose prevention programme [8,26,27].”
BackgroundMethadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Self-citationWhy we need observational studies to evaluate the effectiveness of health care
Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598
Seaman, S. R., Brettle, R. P., & Gore, S. M. (1998) · BMJ · doi:10.1136/bmj.316.7129.426 · Cited by 292
Brugal, M. T., Domingo‐Salvany, A., Puig, R., Barrio, G., García de Olalla, P., & De La Fuente, L. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01089.x · Cited by 228 · cited 1×
“We corroborate and add to the literature showing that methadone substitution therapy is protective against overdose mortality [6,7,19], and provide evidence that the protective effect of treatment extends to methadone detoxification, Therapeutic Communities and psychosocial treatments, and may extend to other pharmaco…”
Result
Cited by
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
“…Gearing et al 1974 Cushman 1977 Grönbladh et al 1990 Caplehorn et al 1994 Fugelstad et al 1995 Fugelstad et al 1998 Scherbaum et al 2002 Fugelstad et al 2007 Clausen et al 2008 Degenhardt et al 2009 Cornish et al 2010 Peles et al 2010 Evans et al 2015 Kimber et al 2015 Nosyk et al 2015…”
BackgroundLarochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999
Santo, T., Clark, B., Hickman, M., Grebely, J., Campbell, G., Sordo, L., Chen, A., Tran, L. T., Bharat, C., Padmanathan, P., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0976 · Cited by 607
Self-citationGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
Metadata
- Authors
- Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna‐Taglianti, F., Faggiano, F., & for the VEdeTTE Study Group
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2007-11-19
- Volume
- 102
- Issue
- 12
- Pages
- 1954-1959
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2083806708
- Cited by
- 220
- References
- 5
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi‐site prospective cohort study. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.02025.x
- The paper
- Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna‐Taglianti, F., Faggiano, F., & for the VEdeTTE Study Group. (2007). Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi‐site prospective cohort study. Addiction. https://doi.org/10.1111/j.1360-0443.2007.02025.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.